Could a Type 2 Diabetes Drug Tackle Kidney Stones? Uncategorized / June 20, 2022 A pooled data analysis of trials of the SGLT2 inhibitor empagliflozin in type 2 diabetes suggests it may lower the risk of kidney stones. However, this is early research. Medscape Medical News